Hamilton acquires BioFluidiX | Learn More

The ADAP STAR™ assay ready workstation is the instrument of choice for the accurate detection of SARS-CoV-2, only days after infection, using the ultrasensitive quantitative Antibody Detection by Agglutination PCR (ADAP) technology by Enable Biosciences. Critically important prevalence testing within the general population is made possible with throughputs of up to 96 samples at a time.

CONTACT US


Specific Kit Supported on this Platform for the SARS-CoV-2 Application

SARS-CoV-2 Rapid Antibody Testing Panel

Workflow

Antibody Detection by Agglutination PCR (ADAP)

Download this Webpage as a Flyer to Share with Colleagues

DOWNLOAD THE FLYER

Additional Resources for the ADAP STAR

See more Assay Ready Workstations
View the AutoLys STAR

Specific Applications

  • Antibody Detection by Agglutination-PCR on the ADAP STAR

    Antibody detection assays, such as ELISA, immunoprecipitation, and radioimmunoassays are important tools to diagnose diseases such as Type 1 Diabetes (T1D)1–3. When performed manually, these common yet labor-intensive assays can take up to 22 hours and are subject to inconsistency between technicians and laboratories.
  • Ultra-Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using the ADAP STAR Assay Ready Workstation

    As of April 16, 2020, there were more than two million confirmed infections of SARS-CoV-2, the virus responsible for Coronavirus Disease 2019 (COVID-19), around the world. In the battle against this rapidly expanding pandemic, successful COVID-19 community screening programs are essential for assessing infection prevalence, aiding identification of infected patients, and enacting appropriate treatment and quarantine protocols.

Hamilton is Customer Service

Whether you need a new instrument or support for one already in the lab, Hamilton is here to support you. Dedicated staff around the world are ready to respond to your request.

Contact Us